REQUEST A DEMO
Total
USD $0.00
Search more companies

Dxn Pharmaceutical Sdn. Bhd. (Malaysia)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Full name: Dxn Pharmaceutical Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dxn Pharmaceutical Sdn. Bhd. is an enterprise in Malaysia, with the main office in Jitra. It operates in the All Other Miscellaneous Ambulatory Health Care Services sector. The enterprise was incorporated on November 20, 1996. 200 (2020) employees currently work for Dxn Pharmaceutical Sdn. Bhd.. From the latest financial highlights, Dxn Pharmaceutical Sdn. Bhd. reported a net sales revenue increase of 45.04% in 2023. There was a total growth of 13.15% in Dxn Pharmaceutical Sdn. Bhd.’s total assets over the same period. The net profit margin of Dxn Pharmaceutical Sdn. Bhd. increased by 6.4% in 2023.

Headquarters
Lot 1109, Mukim Malau,, Daerah Kubang Pasu,
Jitra; Kedah; Postal Code: 06000

Contact Details: Purchase the Dxn Pharmaceutical Sdn. Bhd. report to view the information.

Website: http://www.dxn2uasia.com

Basic Information
Total Employees:
Purchase the Dxn Pharmaceutical Sdn. Bhd. report to view the information.
Outstanding Shares:
Purchase the Dxn Pharmaceutical Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Dxn Pharmaceutical Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Dxn Pharmaceutical Sdn. Bhd. report to view the information.
Incorporation Date:
November 20, 1996
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dxn Pharmaceutical Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
45.04%
Total operating revenue
45.04%
Operating profit (EBIT)
70.64%
Net Profit (Loss) for the Period
75.43%
Total assets
13.15%
Total equity
14.22%
Operating Profit Margin (ROS)
7.25%
Net Profit Margin
6.4%
Return on Equity (ROE)
19.87%
Debt to Equity Ratio
0.28%
Quick Ratio
0.66%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?